Teacher Retirement System of Texas Purchases 3,478 Shares of Liquidia Corporation $LQDA

Teacher Retirement System of Texas raised its holdings in shares of Liquidia Corporation (NASDAQ:LQDA) by 25.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,185 shares of the company’s stock after purchasing an additional 3,478 shares during the quarter. Teacher Retirement System of Texas’ holdings in Liquidia were worth $214,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of LQDA. Adage Capital Partners GP L.L.C. increased its position in shares of Liquidia by 446.7% during the first quarter. Adage Capital Partners GP L.L.C. now owns 461,248 shares of the company’s stock worth $6,803,000 after acquiring an additional 376,872 shares in the last quarter. Nuveen LLC acquired a new position in Liquidia during the 1st quarter valued at about $2,642,000. CenterBook Partners LP purchased a new stake in shares of Liquidia in the first quarter worth approximately $1,786,000. Boothbay Fund Management LLC lifted its holdings in shares of Liquidia by 18.7% in the first quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company’s stock valued at $9,777,000 after purchasing an additional 104,215 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on LQDA. HC Wainwright increased their price target on Liquidia from $35.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research note on Wednesday, October 8th. Wells Fargo & Company assumed coverage on shares of Liquidia in a report on Monday, October 20th. They issued an “overweight” rating and a $31.00 target price for the company. BTIG Research restated a “buy” rating and set a $49.00 price target on shares of Liquidia in a report on Tuesday, November 4th. Finally, Raymond James Financial reaffirmed a “strong-buy” rating and issued a $47.00 price objective on shares of Liquidia in a research report on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $38.56.

Liquidia Trading Up 1.9%

NASDAQ LQDA opened at $27.78 on Wednesday. The stock has a market capitalization of $2.42 billion, a price-to-earnings ratio of -19.29 and a beta of 0.12. Liquidia Corporation has a one year low of $9.71 and a one year high of $29.94. The company has a debt-to-equity ratio of 6.19, a current ratio of 2.20 and a quick ratio of 1.96. The business’s fifty day moving average is $24.47 and its 200-day moving average is $20.07.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Monday, November 3rd. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.41. Liquidia had a negative net margin of 176.04% and a negative return on equity of 296.78%. The company had revenue of $54.34 million during the quarter, compared to analyst estimates of $18.86 million. The business’s revenue was up 1106.7% on a year-over-year basis. Equities research analysts predict that Liquidia Corporation will post -1.51 EPS for the current year.

Insider Activity

In related news, Director Raman Singh sold 45,524 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $25.81, for a total value of $1,174,974.44. Following the transaction, the director owned 31,255 shares in the company, valued at approximately $806,691.55. This represents a 59.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul B. Manning sold 328,268 shares of the stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $28.78, for a total value of $9,447,553.04. Following the transaction, the director directly owned 430,828 shares of the company’s stock, valued at approximately $12,399,229.84. This trade represents a 43.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 920,522 shares of company stock worth $25,512,207. 30.10% of the stock is owned by insiders.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).